S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOME
Main Authors: | D. Noerenberg, F. Briest, C. Hennch, K. Yoshida, J. Nimo, R. Hablesreiter, Y. Takeuchi, D. Sasca, H. Ueno, L. Mansouri, Y. Inoue, L. Wiegand, A. M. Staiger, B. Casadei, M. Ziepert, F. Asmar, P. Korkolopoulou, M. Kirchner, P. Mertins, J. Weiner, E. Toth, T. Weber, A. Warth, T. Schneider, R.-M. Amini, W. Klapper, M. Hummel, V. Poeschel, G. Kanellis, A. Rosenwald, G. Held, E. Campo, K. Stamatopoulos, I. Anagnostopoulos, L. Bullinger, N. Goldschmidt, P. L. Zinzani, C. Bödor, R. Rosenquist, T. P. Vassilakopoulos, G. Ott, S. Ogawa, F. Damm |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000843300.49612.57 |
Similar Items
-
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
by: K. Hoyer, et al.
Published: (2021-04-01) -
Signals in two-sided search
by: Poeschel, F
Published: (2011) -
Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
by: Korkolopoulou, P, et al.
Published: (1996) -
Rethinking labour migration: Covid-19, essential work, and systemic resilience
by: Anderson, B, et al.
Published: (2021) -
The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects
by: Eleni A. Karatrasoglou, et al.
Published: (2023-09-01)